Skip to main content
. 2020 Oct 1;31(4):2289–2302. doi: 10.1007/s00330-020-07303-9

Fig. 5.

Fig. 5

Disease-free survival (DFS) curves of LR-5a (green), LR-5b (blue), and LR-5c (red) subgroups, with LR-5 HCC patients having no, one, and two or three significant MR imaging findings for predicting early recurrence, respectively. DFS differed significantly among three subgroups of LR-5 HCC patients according to the Kaplan–Meier method and log-rank tests